ACADIA Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2002
Cash & Equivalents	194.43	120.62	153.21	331.8	194.47	139.58	71.89	166	102.51	61.85	Upgrade
Short-Term Investments	250.21	301.98	373.27	305.93	507.75	338.76	271.92	365.42	112.99	260.63	Upgrade
Cash & Cash Equivalents	444.64	422.59	526.48	637.73	702.22	478.35	343.82	531.41	215.51	322.49	Upgrade
Cash Growth	5.22%	-19.73%	-17.45%	-9.18%	46.80%	39.13%	-35.30%	146.59%	-33.17%	73.58%	Upgrade
Receivables	102.35	63.08	65.34	50.28	37.87	27.79	18.43	7.14	1.64	0.96	Upgrade
Inventory	40.45	11.56	14.1	9.68	6.34	4.07	5.25	4.18	0	0	Upgrade
Other Current Assets	28.69	10.7	11.91	19.92	13.82	15.9	5.98	5.17	1.84	1.17	Upgrade
Total Current Assets	616.13	507.94	617.82	717.62	760.25	526.11	373.48	547.9	218.99	324.62	Upgrade
Property, Plant & Equipment	56.47	61.59	66.32	56.44	12.7	3.31	2.66	3.08	2.2	0.55	Upgrade
Goodwill and Intangibles	65.49	0	0	1.11	2.59	4.06	5.54	7.02	0	0	Upgrade
Other Long-Term Assets	10.87	18.28	15.98	7.45	7.64	6.73	2.83	3.16	0.7	0.29	Upgrade
Total Long-Term Assets	132.83	79.88	82.3	65	22.93	14.1	11.03	13.26	2.91	0.84	Upgrade
Total Assets	748.96	587.81	700.12	782.62	783.18	540.2	384.51	561.15	221.9	325.46	Upgrade
Accounts Payable	17.54	12.75	6.88	8.49	7.22	3.17	8.79	3.91	1.67	2.02	Upgrade
Deferred Revenue	0	0	0	0	0	0	0	2.64	0	0	Upgrade
Other Current Liabilities	236.71	112.88	89.19	97.47	67.6	56.4	40.24	36.03	20.23	13.82	Upgrade
Total Current Liabilities	254.25	125.63	96.07	105.97	74.83	59.57	49.03	42.59	21.9	15.83	Upgrade
Long-Term Debt	47.8	52.7	56.13	44.46	6.36	0	0	0	0	0	Upgrade
Other Long-Term Liabilities	15.15	9.07	7.03	5.18	2.86	1.56	0.19	0.16	0.23	0.14	Upgrade
Total Long-Term Liabilities	62.95	61.77	63.16	49.64	9.22	1.56	0.19	0.16	0.23	0.14	Upgrade
Total Liabilities	317.2	187.4	159.23	155.61	84.05	61.12	49.22	42.74	22.13	15.97	Upgrade
Total Debt	47.8	52.7	56.13	44.46	6.36	0	0	0	0	0	Upgrade
Debt Growth	-9.29%	-6.11%	26.24%	598.95%	-	-	-	-	-	-	Upgrade
Retained Earnings	-2,430.84	-2,369.55	-2,153.58	-1,985.71	-1,704.12	-1,468.86	-1,223.67	-933.98	-662.59	-498.14	Upgrade
Comprehensive Income	0.02	-0.98	-0.19	0.04	0.3	-0.37	-0.4	0.11	0.01	-0.01	Upgrade
Shareholders' Equity	431.76	400.41	540.89	627.01	699.14	479.08	335.29	518.41	199.76	309.49	Upgrade
Net Cash / Debt	396.84	369.9	470.35	593.27	695.86	478.35	343.82	531.41	215.51	322.49	Upgrade
Net Cash / Debt Growth	7.28%	-21.36%	-20.72%	-14.74%	45.47%	39.13%	-35.30%	146.59%	-33.17%	73.58%	Upgrade
Net Cash Per Share	2.42	2.29	2.93	3.77	4.73	3.78	2.80	4.59	2.14	3.32	Upgrade
Working Capital	361.87	382.31	521.76	611.65	685.42	466.54	324.45	505.31	197.09	308.78	Upgrade
Book Value Per Share	2.64	2.48	3.37	3.98	4.75	3.79	2.73	4.47	1.99	3.18	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).